{"organizations": [], "uuid": "bfe7ab67c864bf5d3ccbcdd92a491585925cefef", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/products-celgene/parents-lawsuit-claims-celgene-unit-used-child-as-guinea-pig-in-phase-ii-drug-trial-idUSL1N1R5256", "country": "US", "domain_rank": 408, "title": "Parents’ lawsuit claims Celgene unit used child as ‘guinea pig’ in phase II drug trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-24T05:56:00.000+03:00", "replies_count": 0, "uuid": "bfe7ab67c864bf5d3ccbcdd92a491585925cefef"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/products-celgene/parents-lawsuit-claims-celgene-unit-used-child-as-guinea-pig-in-phase-ii-drug-trial-idUSL1N1R5256", "ord_in_thread": 0, "title": "Parents’ lawsuit claims Celgene unit used child as ‘guinea pig’ in phase II drug trial", "locations": [], "entities": {"persons": [], "locations": [{"name": "texas", "sentiment": "none"}, {"name": "houston", "sentiment": "none"}], "organizations": [{"name": "celgene", "sentiment": "negative"}, {"name": "juno therapeutics inc", "sentiment": "none"}, {"name": "celgene corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 23 -\nA couple whose daughter died during a phase II clinical study of a novel cancer drug has filed a wrongful death suit against Celgene Corp’s recently acquired Juno Therapeutics Inc, saying the company used the woman as a “human guinea pig” to quickly bring the drug to market.\nIn their Thursday lawsuit filed in Houston federal court, the Texas parents alleged defective design and negligence claims, saying the company had misled them and their 19-year-old daughter about the actual risks of participating in the trial of a new blood cancer drug.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2G13uQy\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.facebook.com/Reuters", "http://bit.ly/2G13uQy", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://instagram.com/reuters/"], "published": "2018-03-24T05:56:00.000+03:00", "crawled": "2018-03-25T11:45:22.014+03:00", "highlightTitle": ""}